edoc

Items where contributor is "Kümmerle, Andrea"

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Date | Item Type | Refereed | No Grouping
Jump to: Article

Article

Kümmerle, A. and Schmid, C. and Bernhard, S. and Kande, V. and Mutombo, W. and Ilunga, M. and Lumpungu, I. and Mutanda, S. and Nganzobo, P. and Tete, D. N. and Kisala, M. and Burri, C. and Blesson, S. and Valverde Mordt, O.. (2021) Effectiveness of Nifurtimox Eflornithine Combination Therapy (NECT) in T. b. gambiense second stage sleeping sickness patients in the Democratic Republic of Congo: report from a field study. PLoS Negl Trop Dis, 15 (11). e0009903.

Vanobberghen, F. and Lweno, O. and Kümmerle, A. and Mwebi, K. D. and Asilia, P. and Simon, B. and Mswata, S. and Schmidlin, S. and Glass, T. R. and Daubenberger, C. and Tanner, M. and Meyer-Monard, S.. (2021) Efficacy and safety of intravenous ferric carboxymaltose compared with oral iron for the treatment of iron deficiency anaemia in women after childbirth in Tanzania: a parallelgroup, open-label, randomised controlled phase 3 trial. Lancet Glob Health, 9 (2). e189-e198.

Kümmerle, A. and Sikalengo, G. and Vanobberghen, F. and Ndege, R. C. and Foe, G. and Schlaeppi, C. and Burri, C. and Battegay, M. and Paris, D. H. and Glass, T. R. and Weisser, M. and Marzolini, C. and Kiularco Study Group, . (2021) Recognition and management of clinically significant drug-drug interactions between antiretrovirals and co-medications in a cohort of people living with HIV in rural Tanzania: a prospective questionnaire-based study. J Antimicrob Chemother, 76 (10). pp. 2681-2689.

Kuemmerle, Andrea and Schmid, Caecilia and Kande, Victor and Mutombo, Wilfried and Ilunga, Medard and Lumpungu, Ismael and Mutanda, Sylvain and Nganzobo, Pathou and Ngolo, Digas and Kisala, Mays and Valverde Mordt, Olaf. (2020) Prescription of concomitant medications in patients treated with Nifurtimox Eflornithine Combination Therapy (NECT) for T.b. gambiense second stage sleeping sickness in the Democratic Republic of the Congo. PLoS Neglected Tropical Diseases, 14. e0008028.

Nzolo, Didier and Kuemmerle, Andrea and Lula, Yves and Ntamabyaliro, Nsengi and Engo, Aline and Mvete, Bibiche and Liwono, Jerry and Lusakibanza, Mariano and Mesia, Gauthier and Burri, Christian and Mampunza, Samuel and Tona, Gaston. (2019) Development of a pharmacovigilance system in a resource-limited country : the experience of the Democratic Republic of Congo. Therapeutic advances in drug safety, 10. p. 2042098619864853.

van Hunsel, F. and van de Koppel, S. and Skalli, S. and Kuemmerle, A. and Teng, L. and Wang, J. B. and Barnes, J.. (2019) Analysis of hepatobiliary disorder reports associated with the use of herbal medicines in the global suspected ADR database Vigibase. Frontiers in pharmacology, 10. p. 1326.

Samouda, Hanen and Ruiz-Castell, Maria and Bocquet, Valery and Kuemmerle, Andrea and Chioti, Anna and Dadoun, Frédéric and Kandala, Ngianga-Bakwin and Stranges, Saverio. (2018) Geographical variation of overweight, obesity and related risk factors : findings from the European Health Examination Survey in Luxembourg, 2013-2015. PLoS ONE, 13 (6). e0197021.

Nzolo, Didier and Engo Biongo, Aline and Kuemmerle, Andrea and Lusakibanza, Mariano and Lula, Yves and Nsengi, Ntamabyaliro and Nsibu Ndosimao, Celestin and Tona Lutete, Gaston and Van Geertruyden, Jean-Pierre. (2018) Safety profile of fractional dosing of the 17DD yellow fever vaccine among males and females: experience of a community-based pharmacovigilance in Kinshasa, DR Congo. Vaccine, 36 (41). pp. 6170-6182.

Kümmerle, A. and Mäder, M. and Sartori, D. and Lazarova, A. and Urich, M. and Dodoo, A. and Olsson, S. and Burri, C.. (2017) Contribution of adverse events reporting of HIV antiretrovirals to vigibase : comparison between Sub-Saharan Africa and the rest of the world. Drug safety, 40 (10). pp. 987-988.

Kümmerle, A. and Sartori, D. and Maeder, M. and Lazarova, A. and Urich, M. and Dodoo, A. and Olsson, S. and Burri, C.. (2017) Spontaneous reporting characteristics of HIV antiretrovirals in vigibase: disproportionate analysis between Sub-Saharan Africa and the rest of the world. Drug safety, 40 (10). pp. 988-989.